{
    "Trade/Device Name(s)": [
        "OSOM C. difficile Toxin A/B Test"
    ],
    "Submitter Information": "Genzyme Diagnostics",
    "510(k) Number": "K102242",
    "Predicate Device Reference 510(k) Number(s)": [
        "K041951"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LLH"
    ],
    "Summary Letter Date": "December 8, 2010",
    "Summary Letter Received Date": "December 9, 2010",
    "Submission Date": "08/05/2010",
    "Regulation Number(s)": [
        "21 CFR 866.2660"
    ],
    "Regulation Name(s)": [
        "Microorganism differentiation and identification device"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Clostridium difficile Toxin A",
        "Clostridium difficile Toxin B"
    ],
    "Specimen Type(s)": [
        "Human stool",
        "Human fecal specimen"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Dipstick technology",
        "Sandwich immunoassay"
    ],
    "Methodologies": [
        "Qualitative immunochromatographic detection"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for OSOM C. difficile Toxin A/B Test, a qualitative immunochromatographic dipstick assay for C. difficile toxins A and B in stool specimens",
    "Indications for Use Summary": "Qualitative detection of Clostridium difficile toxins A and/or B in human stool samples as an aid in the diagnosis of C. difficile-associated disease in symptomatic patients",
    "fda_folder": "Microbiology"
}